Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Spending Bill Goes To House Panel At Lower Level Than Senate

This article was originally published in The Pink Sheet Daily

Executive Summary

A House appropriations subcommittee on June 6 will mark up a bill that would give FDA $44 million less to spend in Fiscal 2013 than a measure produced by the Senate Appropriations Committee, indicating a conference committee will be the final arbiter of agency funding.

Advertisement

Related Content

Increased FDA China Inspections Backed By House Panel, While Purse Strings Pulled Still Tighter
FDA Largely Ignored At Appropriations Subcommittee Mark-Up
House Approps Bill Would "Harden" Science Requirements For FDA Rules, Guidance

Topics

Advertisement
UsernamePublicRestriction

Register

PS074239

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel